Dynavax Technologies Corporation

NasdaqGS DVAX

Dynavax Technologies Corporation Gross Profit for the Trailing 12 Months (TTM) ending September 30, 2024: USD 216.09 M

Dynavax Technologies Corporation Gross Profit is USD 216.09 M for the Trailing 12 Months (TTM) ending September 30, 2024, a -10.79% change year over year. Gross profit is the difference between revenue and the cost of revenue, representing the profit earned from core business operations.

Dynavax Technologies Corporation Gross Profit for the Trailing 12 Months (TTM) ending September 30, 2023 was USD 242.21 M, a -48.96% change year over year.
Dynavax Technologies Corporation Gross Profit for the Trailing 12 Months (TTM) ending September 30, 2022 was USD 474.58 M, a 196.05% change year over year.
Dynavax Technologies Corporation Gross Profit for the Trailing 12 Months (TTM) ending September 30, 2021 was USD 160.30 M, a 597.31% change year over year.
Dynavax Technologies Corporation Gross Profit for the Trailing 12 Months (TTM) ending September 30, 2020 was USD 22.99 M, a 102.39% change year over year.

Key data

Date	Gross Profit	Operating Income	EBIT	EBITDA

NasdaqGS: DVAX

Dynavax Technologies Corporation

CEO	Mr. Ryan Spencer
IPO Date	Feb. 19, 2004
Location	United States
Headquarters	2100 Powell Street
Employees	408
Sector	Health Care
Industries Vaccines Biotechnology Pharmaceuticals

Description

Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufactures and sells CpG 1018, the adjuvant used in HEPLISAV-B. Dynavax Technologies Corporation has a collaboration agreement with Valneva Scotland Limited; agreement with Serum Institute of India Pvt. Ltd.; and sublicense agreement with Merck, Sharp & Dohme Corp. The company was formerly known as Double Helix Corporation and changed its name to Dynavax Technologies Corporation in September 1996. Dynavax Technologies Corporation was incorporated in 1996 and is headquartered in Emeryville, California.

Key trends

Past 5 years